Monday June 1, 2020

Merrion Pharma to hand back €4.5m to investors in liquidation

Drug company announced it planned to voluntarily wind up

Ian Guider

Markets Editor

@ianguider
11th September, 2016
John Fox of Merrion Pharma Pic: Fearghal Phillips

Merrion Pharma is understood to be contacting broking firms to advise clients to vote on the company’s winding-up plan.

Merrion, a drug company backed by Declan Ryan, announced last month that it planned to voluntarily wind up and hand back €4.5 million of cash to investors. After selling intellectual property assets last year to drug giant Novo, Nordisk Merrion set about turning itself into an investment company focused on the healthcare sector, but...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 4 weeks ago

What’s coming up today and what you might have missed

Hannah O’Brien | 5 months ago